Qualigen Therapeutics, Inc. (QLGN)
Market Closed
18 Nov, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
3. 21
+0.17
+5.59%
$
5.43M Market Cap
- P/E Ratio
0% Div Yield
368,768 Volume
-2.7 Eps
$ 3.04
Previous Close Day Range
2.86 3.34
Year Range
1.61 8.81
Want to track QLGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Why Is Qualigen Therapeutics (QLGN) Stock Down 22% Today?
Qualigen Therapeutics (NASDAQ: QLGN ) stock is falling on Monday as the clinical-stage therapeutics company's shares come off of a massive rally on Friday. That Friday rally resulted in shares of QLGN stock closing out normal trading hours up 109.2%.
Investorplace | 1 year ago
Why Is Qualigen (QLGN) Stock Up 141% Today?
Qualigen (NASDAQ: QLGN ) stock is rocketing higher on Friday after the clinical-stage therapeutics company secured a new loan. Qualigen reached an agreement with an investor for a $2 million Senior Note due July 8, 2025 with an 18% annual interest rate.
Investorplace | 1 year ago
Why Is Qualigen Therapeutics (QLGN) Stock Down 12% Today?
Qualigen Therapeutics (NASDAQ: QLGN ) stock is sliding lower on Monday as the clinical-stage therapeutics company's shares come off of a rally on Friday. That rally saw shares of QLGN stock soar more than 59% higher during normal trading hours.
Investorplace | 1 year ago
2025 © Marketlog. All Rights Reserved.
